Form 8-K Filing - Personalis, Inc.

On March 13, 2026, Personalis, Inc. announced a change in its executive team. Richard Chen has been appointed as the Company's President, in addition to his existing roles as Executive Vice President, R&D, and Chief Medical Officer. This appointment was recommended by CEO Christopher Hall, who previously held the President title. Dr. Chen, 55, has a comprehensive background in R&D and medical roles within the company since 2011, including co-founding Ingenuity Systems. His compensation will be adjusted with an increased base salary to $570,000 effective April 1, 2026, and an enhanced performance bonus target of 70%. He will also be granted stock options for 37,500 shares and restricted stock units for 6,250 shares, subject to vesting schedules tied to his continued service with the company under the 2019 Equity Incentive Plan.